Hormonal Mechanisms in Essential Hypertension

1. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89:3A-9A,2002.10.1016/S0002-9149(01)02321-9 Search in Google Scholar

2. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42:1075–1081.2003.10.1161/01.HYP.0000100443.09293.4F14581295 Search in Google Scholar

3. Yan C, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol 23:26–36, 2003. Search in Google Scholar

4. Carey RM. Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens 14:67-71,2005.10.1097/00041552-200501000-0001115586018 Search in Google Scholar

5. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289:H2281–H2290,2005.10.1152/ajpheart.00618.2005720356616055515 Search in Google Scholar

6. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ. Prevention of angiotensin IIinduced cardiac remodeling by angiotensin-(1–7). Am J Physiol Heart Circ Physiol 292: H736–H742,2007.10.1152/ajpheart.00937.200617098828 Search in Google Scholar

7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82–C97,2007. Search in Google Scholar

8. Katy Rivard, Scott A. Grandy, Annie Douillette, Pierre Paradis, MonaNemer, Bruce G. Allen, and Céline Fiset. Over expression of type 1 angiotensin II receptors impairs excitation-contraction coupling in themouse heart. AJP – Heart, vol. 301 no. 5 H2018-H2027, 2011.10.1152/ajpheart.01092.201021856918 Search in Google Scholar

9. Victor M Pulgar, Henry Yamashiro, James C Rose, Lorna G Moore.Role of the AT2 receptor in modulating the angiotensin II contractileresponse of the uterine artery at mid-gestation. Journal of Renin-Angiotensin-Aldosterone System vol. 12 no. 3 176-183, 2011.10.1177/1470320310397406312686821421654 Search in Google Scholar

10. Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 98 463–471.2006.10.1161/01.RES.0000205761.22353.5f16514079 Search in Google Scholar

11. Kaplan NM. Resistant hypertension. Journal of Hypertension. 23(8):1441–1444, 2005.10.1097/01.hjh.0000174968.72212.ac16003165 Search in Google Scholar

12. Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F,et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension. 48:239–45.2006.10.1161/01.HYP.0000231338.41548.fc16785327 Search in Google Scholar

13. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens. 25:177–86.2007.10.1097/HJH.0b013e3280108e6f17143190 Search in Google Scholar

14. Caprio M, Fève B, Claës A, Viengchareun S, Lombès M, Zennaro MC. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 21:2185 94.2007.10.1096/fj.06-7970com17384139 Search in Google Scholar

15. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor gamma, and pro-inflammatory adipokines. Circulation. 117:2253–61.2008.10.1161/CIRCULATIONAHA.107.748640274664718427128 Search in Google Scholar

16. Lamounier-Zepter V, Ehrhart-Bornstein M. Fat tissue metabolism and adrenal steroid secretion. Curr Hypertens Rep.J 8:30–4.2006.10.1007/s11906-006-0038-316600157 Search in Google Scholar

17. Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, et al.Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens. 20:855–61.2007.10.1016/j.amjhyper.2007.03.01217679033 Search in Google Scholar

18. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1–7): an evolving story in cardiovascular regulation. Hypertension 47:515–521,2006. Search in Google Scholar

19. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289:H2281–H2290,2005.10.1152/ajpheart.00618.2005720356616055515 Search in Google Scholar

20. Freele EM, Connel JM. Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol 15:1993-2001,2004. Search in Google Scholar

21. Brown NJ. Aldosterone and vascular inflammation. Hypertension.51:161–7,2008.10.1161/HYPERTENSIONAHA.107.09548918172061 Search in Google Scholar

22. Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, et al. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc Res. 76:506–16.2007.10.1016/j.cardiores.2007.07.00817706954 Search in Google Scholar

23. Carrie A. Northcott, Greg D. Fink, Hannah Garver, Joseph R. Haywood, Erinn L. Laimon-Thomson, Jonathon L. McClain, Paulo W. Pires, William E. Rainey, Christine S. Rigsby and Anne M. Dorrance, The Development of Hypertension and Hyperaldosteronism in a Rodent Model of Life-Long Obesity. Endocrinology, vol. 153 no. 4 1764-1773, 2012.10.1210/en.2011-1176332025922355066 Search in Google Scholar

24. Ritz E. How Little Aldosterone is Able to Raise Blood Pressure? CJASN vol. 4 no. 4:703-710, 2009.10.2215/CJN.01220209 Search in Google Scholar

25. Catanzaro DF. Molecular biology of renin and regulation of its gene. In: Singh AK, Williams GH, eds. Textbook of Nephro-Endocrinology. San Diego, CA: Academic; 2017:389–400.91.10.1016/B978-0-12-803247-3.00022-2 Search in Google Scholar

26. Carey MR, Padia SH. Physiology and regulation of the renin–angiotensin–aldosterone system. In: Singh AK, Williams GH, eds. Textbook of Nephro-Endocrinology, 2nd ed. San Diego, CA: Academic; 2017:1–23.276.10.1016/B978-0-12-803247-3.00001-5 Search in Google Scholar

27. Kosachunhanun N, Hunt SC, Hopkins PN, Williams RR, Jeunemaitre X, Corvol P, Ferri C, Mortensen RM, Hollenberg NK, Williams GH. Genetic determinants of nonmodulating hypertension. Hypertension. 2003;410.1161/01.HYP.0000095615.83724.8214530292 Search in Google Scholar

28. Kolovou V, Lagou E, Mihas C, Vasiliki G, Katsiki N, Angiotensinogen (AGT) M235T, AGT T174M and angiotensin-1-converting enzyme (ACE) I/D gene polymorphisms in essential hypertension: effects on ramipril efficacy Open Cardiovasc Med J. 2015;9(1):118–126.10.2174/1874192401509010118476866027006715 Search in Google Scholar

29. Srivastava K, Chandra S, Bhatia J, Narang R, Saluja D. Association of angiotensinogen (M235T) gene polymorphism with blood pressure lowering response to angiotensin converting enzyme inhibitor (enalapril). J Pharm Pharm Sci. 2012;15(3):399–406.10.18433/J3KW3B22974788 Search in Google Scholar

30. Xi B, Shen Y, Reilly KH, Wang X, Mi J. Recapitulation of four hypertension susceptibility genes (CSK, CYP17A1, MTHFR, and FGF5) in East Asians. Metabolism 2013;62(2):196–203.10.1016/j.metabol.2012.07.00822959498 Search in Google Scholar

31. Calhoun DA. Aldosterone and cardiovascular disease: smoke and fire. Circulation. 14:2572–2574, 2006. Search in Google Scholar

32. Lemarie CA, Paradis P, Schiffrin EL. New insights on signalling cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med. 86:673–678, 2008.10.1007/s00109-008-0323-518368382 Search in Google Scholar

33. Goodfriend TL. Obesity, sleep apnea, aldosterone and hypertension. Current Hypertension Reports. 10(3):222-226, 2008.10.1007/s11906-008-0042-x18765094 Search in Google Scholar

34. Ramachandran V, Ismail P, Stanslas J, Shamsudin N. Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects. Cardiovasc Diabetol. 2009;8(1):11.10.1186/1475-2840-8-11265646419243623 Search in Google Scholar

35. Reckelhoff J.F, Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199-1208.10.1161/01.HYP.37.5.119911358929 Search in Google Scholar

36. Reckelhoff J.F, Sex Steroids, Cardiovascular Disease and Hypertension: Unanswered Questions and Some speculations, Hypertension, 2005;45(2): 170-174. Search in Google Scholar